Consolidated Statements of Stockholders’ Investment - USD ($) shares in Thousands, $ in Thousands	12 Months Ended							75 Months Ended
	Jan. 29, 2022	Jan. 30, 2021		Feb. 01, 2020		Feb. 02, 2019		Jan. 29, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	$ 391,036	$ 328,983		$ 336,049
Net income	174,313	74,266		27,344
Issuance of shares through the Company’s equity plans	2,658	1,858		475
Declaration of dividends ($0.25 per common share)		0
Purchase of shares under the stock repurchase program	(267,826)	(16,717)		(34,904)				$ (933,900)
Settlement of net share equity awards	(3,257)	(897)		(555)
Stock-based compensation	5,540	3,799		2,653
Balance-end of period	$ 291,515	391,036		$ 328,983		$ 336,049		$ 291,515
Accounting Standards Update [Extensible List]				Accounting Standards Update 2016-13 [Member]		Accounting Standards Update 2016-02 [Member]
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		$ (256)	[1]	$ (2,079)	[2]
Balance-end of period				$ (256)	[1]	$ (2,079)	[2]
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	39,380	39,141		38,983
Balance-beginning of period	$ 394	$ 391		$ 390
Issuance of shares through the Company’s equity plans (in shares)	231	239		158
Issuance of shares through the Company’s equity plans	$ 2	$ 3		$ 1
Balance-end of period (in shares)	39,611	39,380		39,141		38,983		39,611
Balance-end of period	$ 396	$ 394		$ 391		$ 390		$ 396
Paid-In Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	194,534	188,879		185,752
Issuance of shares through the Company’s equity plans	2,656	1,855		474
Stock-based compensation	5,540	3,799		2,653
Balance-end of period	202,729	194,534		188,879		185,752		202,729
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period	858,951	784,942		759,677
Net income	174,313	74,266		27,344
Declaration of dividends ($0.25 per common share)	(10,949)
Balance-end of period	$ 1,022,317	858,951		784,942		759,677		$ 1,022,317
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period		$ (256)	[1]	(2,079)	[2]
Balance-end of period				$ (256)	[1]	$ (2,079)	[2]
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance-beginning of period (in shares)	22,901	22,280		20,686
Balance-beginning of period	$ (662,843)	$ (645,229)		$ (609,770)
Purchase of shares under the stock repurchase program (in shares)	3,371	578		1,565
Purchase of shares under the stock repurchase program	$ (267,826)	$ (16,717)		$ (34,904)
Settlement of net share equity awards (in shares)	46	43		29
Settlement of net share equity awards	$ (3,257)	$ (897)		$ (555)
Balance-end of period (in shares)	26,318	22,901		22,280		20,686		26,318
Balance-end of period	$ (933,927)	$ (662,843)		$ (645,229)		$ (609,770)		$ (933,927)

[1] Adoption of ASU 2016-13, Topic 326, Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 7, 2021.

[2] Adoption of ASU 2016-02, Topic 842, Leases. See Note 2, Recent Accounting Pronouncements, in our Annual Report on Form 10-K filed on April 16, 2020.